Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 19 Source: CRO
- €2.5 billion turnover
-
€1.5 billion
profit - 400 employees
-
31st Dec 18 Source: CRO
- €2.3 billion turnover
-
€1.3 billion
profit - 500 employees
- 5 more years available »
Ranking
By Turnover
(€2.5 billion)- 47th in Top Companies
- 10th in Health
- 6th in Pharma
By Employees
(400)- 429th in Top Companies
- 65th in Health
- 39th in Pharma
- 400
- €2.5 billion
Employees
- Shane Doyle Senior vice president
Latest News
- 3:25pm YouTube suspends Sky News Australia for one week
- 2:59pm Pfizer and Moderna ramp up EU Covid vaccine prices
- 10:56am RTÉ will require rescue if funding issues not addressed
- Jul 31 Vodafone Ireland to hike prices annually by at least 3%
- Jul 31 Fibrus Networks targets northern England in major expansion